FLAG-IDA regimen (fludarabine, cytarabine, idarubicin and G-CSF) in the treatment of patients with high-risk myeloid malignancies

1. De La Rubia, J.
2. Regadera, A.I.
3. Martín, G.
4. Cervera, J.
5. Sanz, G.F.
6. Martínez, J.A.
7. Jarque, I.
8. García, I.
9. Andreu, R.
10. Moscardó, F.
11. Jiménez, C.
12. Mollá, S.
13. Benlloch, L.
14. Sanz, M.A.